INTRODUCTION
The use of CT angiography (CTA) to describe both the anatomy of the normal portal vasculature and the anatomy of congenital portosystemic shunts in small animals is well described (Frank et al. 2003 , Zwingenberger & Schwarz 2004 , Zwingenberger et al. 2005 , Echandi et al. 2007 , Nelson & Nelson 2011 , White & Parry 2013 , 2016a , 2016b , Fukushima et al. 2014 . For many years, intraoperative mesenteric portography (IOMP) was considered the "gold standard" for the diagnosis of portosystemic vascular abnormalities in dogs and cats (White et al . 2003 ) . Recently, the morphology of the normal extrahepatic portal vein has been compared using both IOMP and CTA, and a conclusion was reached that CTA consistently showed more detail of the extrahepatic portal vein and its tributaries . In addition, in dogs and cats suffering with a congenital extrahepatic portosystemic shunt (EHPSS), the preoperative findings of CTA have been compared with the findings of shunt preligation IOMP ). This study concluded that preligation IOMP was consistently outperformed by preoperative CTA in all cases except those with an EHPSS involving the right gastric vein and that, as such, there could be little indication for performing preligation IOMP in cases that had already undergone diagnostic preoperative CTA .
IOMP can also be performed following the localisation and temporary full ligation of a congenital EHPSS (TFL-IOMP), and it has been recognised that such studies provide different and clinically useful information when compared with IOMPs obtained before surgical manipulation of the shunt. For example, TFL-IOMPs can confirm that the correct shunting vessel has been recognised and encircled accurately and that there are no other shunting vessels (White et al . 2003 , Lee et al . 2006 , Lipscomb et al . 2009 ). In addition, TFL-IOMP provides an indication of the character of the intrahepatic portal vasculature ttp://www.bsava.com/ 
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-information used at the time of surgery to help decide whether or how the shunt should be attenuated (White et al . 2003 , Lee et al . 2006 , Lipscomb et al . 2009 ). The information obtained from a TFL-IOMP indicates the prognosis following shunt attenuation surgery; the more developed the intrahepatic portal vasculature, the better the long-term prognosis following shunt closure surgery (Lee et al . 2006 , Lipscomb et al . 2009 ).
The purpose of this study was to compare and contrast the imaging modalities of preoperative CTA and TFL-IOMP in dogs and cats suffering with a congenital EHPSS and to utilise this information to make recommendations for their use in the clinical management of congenital EHPSSs.
METHODS
This retrospective study reviewed images of dogs and cats with congenital EHPSS investigated and managed between 2009 and 2016. The inclusion criteria were: diagnosis of congenital EHPSS, a preoperative CTA less than four weeks before surgery and IOMP after temporary full ligation of the shunting vessel (TFL-IOMP).
Data on breed, signalment (age, gender, neutering status), imaging investigation, type of portosystemic shunt and gross surgical findings were collected and reviewed.
CTA was performed under anaesthesia using a 16-slice multidetector unit (Brightspeed, General Electric Medical Systems) as described previously (White & Parry 2016a , 2016b . Briefly, images were acquired using a 0·625 mm or 1·25 mm slice collimation, depending on the size of the animal, 120 kVp and variable mAs. Patients were positioned in sternal recumbency, and apnoea was induced prior to image acquisition to reduce respiratory motion. Scanned field of view and displayed field of view (DFOV) were selected according to the size of the animal. The collimator pitch was 0·938. Pre-and postintravenous contrast with a dose of 600 mg I/kg Iohexol (Omnipaque, GE Healthcare) images were obtained using a standard algorithm (medium frequency reconstruction kernel) and a 512×512 matrix and were viewed using a window and level optimised for soft tissue (window 400HU, level 50HU). Contrast was injected at a speed of 2·0 to 3·0 mL/s (depending on the size of the animal and, consequently, the size of intravenous catheter) using a pressure injector (Medrad Stellant CT injection system, Bayer Healthcare Medical Care). To optimise contrast enhancement, a transverse slice over the mid-abdomen was selected and repetitively examined while contrast injection was performed. At the onset of opacification of the portal vessels, a complete abdominal dual-phase CTA examination was performed using proprietary bolus tracking software with an automated trigger threshold of 120HU to start the scan. The trigger region of interest was positioned over the portal vein at the level of the porta hepatis in all dogs and cats in the central aspect of the vessel to allow for respiratory motion. A further tissue pool phase was then performed without using bolus tracking. Studies were assessed in their native format using multi-planar reformatting (MPR) and maximum intensity projection (MIP). Volume-rendered images were not utilised. All CTA studies were reviewed by both authors.
TFL-IOMP was carried out during surgery with the patients positioned in dorsal recumbency. A mobile image intensification unit (OEC Fluorostar 7900, General Electric Medical Systems) was used to obtain ventrodorsal images of the cranial abdomen following the temporary, full ligation of the shunting vessel (White et al. 1996 , White et al. 1998 . A jejunal vein was cannulated with a catheter (20 or 22 gauge). The shunting vessel was located and encircled with a ligature of either 3-0 or 2-0 polypropylene (Prolene, Ethicon UK Ltd.) close to its communication with the systemic vein. The shunt was temporarily fully closed using the encircling ligature as a vascular snare, and although the time of total occlusion was not measured specifically, in none of the cases was the total occlusion time longer than 90 seconds. Although mesenteric (portal) venous pressures were not specifically recorded, they were assessed to ensure that they did not exceed 20 cmH 2 O during the period of TFL-IOMP in any of the cases. A mask was applied to create a digital subtraction angiogram, and a bolus of non-ionic iodinated contrast agent (iohexol, Omnipaque, GE Healthcare, Norway) was injected into the jejunal vein to produce the images. The total dose of iodine did not exceed 600 mg I/kg. The contrast was injected by hand using a 10 or 20 mL syringe. Angiograms were recorded digitally and were reviewed retrospectively by both authors as video loops.
The CTA and TFL-IOMP images were evaluated using a method adapted from those described previously (Macdonald et al . 2002 , Zwingenberger & Schwarz 2004 , Lee et al . 2006 . Intrahepatic portal vein arborisation was assessed for the presence or absence of a portal vein entering the liver; principal right and left portal branches; branching of the principal portal branches; and primary, secondary and tertiary branching of the principal branches (Macdonald et al . 2002 ) . Furthermore, a subjective assessment of the size and opacity (attenuation) of the intrahepatic vessels was conducted between the two modalities.
The TFL-IOMP and CTA data were reviewed in a random order using simple randomisation of the data.
RESULTS
In total, 14 dogs and five cats met the inclusion criteria. No patients were excluded due to poor image quality. Three dogs had a shunt emanating from the left gastric vein, of which two had a left gastrophrenic shunt and one had a left gastro-azygos shunt ( White & Parry 2013 ) . Six dogs had a shunt involving the right gastric vein, of which three had a type Ai, one had a type Aii and two had a type Aiii (no dogs had a type B shunt) . Three dogs had a splenocaval shunt (White & Parry 2016a ) . Two dogs had a shunt involving the left colic vein, of which one had a shunt entering the caudal vena cava and one had a shunt entering the cranial rectal vein (White & Parry 2016b ) . Of the five cats, two had a left gastrophrenic shunt, one had a left gastrocaval shunt, one a splenocaval shunt and one a shunt involving the left colic vein (which inserted into the caudal vena cava). These extrahepatic findings on CTA were confirmed at surgery. The age, breed and gender distribution of the patients with various different shunt types were consistent with previous studies. More shunts involving the right gastric vein were identified in this study than in previous studies (see Table 1 ).
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CT angiography
In all cases, CTA documented a portal vein entering the liver, but there was variation in the appearance of intrahepatic arborisation according to shunt type. In all left gastrophrenic, left gastrocaval, left gastro-azygos and splenocaval shunts, as well as the three shunts involving the left colic vein, CTA documented the portal vein entering the liver; the principal right and left portal branches; the primary, secondary and tertiary branching of the principal branches; and the opacification of the right and left lobes of the liver. In all patients with shunts involving the right gastric vein, CTA showed the portal vein entering the liver. However, of these six cases, the principal right and left portal branches were only identified in five dogs and the primary, secondary and tertiary branching of the principal branches in three dogs.
Temporary, full-ligation, intraoperative mesenteric portography
In all cases, the portal vein entering the liver and the principal right and left portal branches were identified. The primary, secondary and tertiary branching of the principal branches were apparent in all cases (see Table 2 ).
Subjectively, the divisions of the intrahepatic portal branches appeared slightly larger and more intensely contrast-enhancing on IOMP images compared with the CTA images. This subjective finding was consistent in all IOMP video loops compared with the corresponding CTA images (see Fig. 1 ).
No patients suffered any obvious or apparent intraoperative complications ( e.g. changes in anaesthetic monitoring physiological parameters) as a result of the temporary full occlusion of the shunt or the TFL-IOMP.
DISCUSSION
With the exception of those shunts involving the right gastric vein, the identification of the intrahepatic arborisation was similar on CTA and TFL-IOMP images, with all primary, secondary and tertiary portal divisions identified. Subjectively, there was improved contrast enhancement, as well as slight enlargement of the intrahepatic portal vasculature, on TFL-IOMP when compared with CTA. This finding has an intuitive explanation. The non-selective nature of CTA means that the contrast agent is injected into a peripheral systemic vein, passing multiple capillary networks before reaching the portal venous system. Contrast detection will depend on the degree of contrast dilution, the sensitivity of the scanner to detect the contrast and the timing of the acquisition of the scans relative to contrast injection. The pressure with which the contrast agent is deposited in the liver will depend, to a large extent, on portal venous pressure. On the other hand, TFL-IOMP is highly likely to achieve a far higher pressure during the hand injection because contrast is injected into an effectively closed system (with the shunt vessel ligated). This will lead to greater concentrations of contrast within the hepatic portal vasculature at a higher pressure than that achievable by CTA and will therefore increase the size and visibility of the intrahepatic portal veins, provided the shunt vessel has been adequately ligated. The choice of mesenteric vein tributary that was used for the technique did not appear to affect the identification of the intrahepatic portal vasculature, nor was there variation in the appearance of the intrahepatic vasculature based on shunt type with TFL-IOMP. A greater number of dogs with shunts involving the right gastric vein were identified in this study (43%) than in previous studies ( e.g. 21% in a recent review; White et al . 2017 ) . A definitive reason for this variation was not identified. However, it may be due to the relatively small number of patients included in this study. This small sample size is a study limitation, implying that it is not possible to conclude definitely that these findings apply to all patients with congenital EHPPSs. For example, patients without intrahepatic portal vasculature (portal hypoplasia) were not available for inclusion in this study, and it is, therefore, not possible to conclude whether findings from preoperative CTA and TFL-IOMP would be significantly different in such cases.
The appearance of the intrahepatic vasculature varied between CTA and TFL-IOMP. CTA showed a reduction in intravascular contrast enhancement when shunts involved the right gastric vein, whereas patients with this shunt type consistently had good intrahepatic vascular enhancement on TFL-IOMP. Variation in the preoperative CTA appearance of the intrahepatic vasculature with shunts involving the right gastric vein has been described previously . Briefly, preferential flow of contrast and streamlining of the contrast agent within the portal vasculature may cause blood within the portal vein to mix incompletely and remain streamlined, with discrete channels of flow permitting the liver to receive blood from discrete viscera. Whether the viscosity of the contrast agent plays a role in streamlining has, to the authors' knowledge, not been investigated. A laminar flow appearance of contrast on preligation IOMP has been observed previously, and this has been described as a potential source of variation in the appearance of the intrahepatic portal vasculature when using this imaging modality . Such a laminar flow appearance was not identified on any TFL-IOMP in this current study, and its absence was considered likely due to supra-physiological pressures achieved by the hand injection of the contrast agent into what was effectively a closed circuit. Further studies are required to investigate this phenomenon in more detail.
A further explanation as to why preoperative CTA was outperformed by TFL-IOMP is given by the proportion of blood entering the liver from the portal vasculature in patients with a portosystemic shunt. In patients with a portosystemic shunt, a proportion of the portal blood will bypass the liver, entering directly into a systemic vein. In cases in which the 'shunting' proportion is high, there will be a comparative reduction in intrahepatic portal blood flow. It is not surprising, therefore, that in patients with an EHPSS there would be a reduction in the highlighting of the intrahepatic portal vasculature for CTA when compared with TFL-IOMP. Variation between the two modalities may also be influenced by a number of other factors, such as the positioning of the patient at the time of the examination. For CTA examinations, patients were always in sternal recumbency, and for TFL-IOMP, patients were invariably in dorsal recumbency. Such differences in positioning are likely to be associated with differences in both intraabdominal and intra-thoracic pressures, which in turn might have an effect on contrast enhancement of the portal system. Whether this alteration in patient position has any such effect is yet to be established. In addition, other factors might have effects on the differences in the contrast enhancement of the portal system between the two modalities, for instance, an 'open' (TFL-IOMP) versus 'closed' (CTA) abdomen and exteriorisation and the placement of traction on the small intestine and its mesentery when performing the IOMP. These factors were not specifically investigated in the current study, although standard, recognised techniques were used for both CTA and the TFL-IOMP. A previous study comparing CTA with premanipulation and ligation of the shunt IOMP indicated no inherent compromise to the contrast enhancement of the portal system between the two modalities . The same basic methodology for CTA and IOMP were utilised in the current study in an attempt to mitigate the potential issues associated with contrast enhancement of the portal system.
Further variation may be due to the timing of the study on CTA. In all cases, a bolus tracking procedure was undertaken, but even with strict adherence to protocol, some variation in the visibility of portal vasculature due to variation in the timing of triggering of the study is unavoidable. It is, after all, a 'snap-shot' of the portal vasculature, obtained in a transient time frame. This is not the case for TFL-IOMP, which is a dynamic study. Similarly, TFL-IOMP instantaneously highlights the entire intrahepatic portal vasculature during the operation. On the other hand, CTA produces a vast amount of data that take time to analyse. The assessment of individual portal vein branches requires the assessment of multiple stacked images, in native format, MPR and maximum intensity projection (MIP).
Volume-rendered images of the CTA images were not used in this study. This is because the smaller diameter of the intrahepatic vasculature and reduced contrast enhancement of the vessels (compared with the extrahepatic portal vasculature) meant that volumerendered images proved to be unsatisfactory for assessment.
TFL-IOMP was better at assessing the intrahepatic portal vasculature than both CTA and preoperative IOMP (as discussed in ). Both White et al . ( 2003 ) and Lee et al . ( 2006 ) showed that intrahepatic portal vasculature is better documented after temporary shunt ligation, compared with preligation, based on IOMP findings in dogs. Furthermore, Lee et al . ( 2006 ) confirmed that a well-developed intrahepatic portal vasculature identified on IOMP following the temporary full ligation of an EHPSS could be used as a positive prognostic indicator for clinical outcome. Lipscomb et al . ( 2009 ) showed similar findings in cats. As CTA is a non-selective technique, contrast is not administered under pressure into the portal circulation, as with IOMP, and this may be expected to underestimate portal vasculature arborisation ( Zwingenberger et al . 2013 ) . The findings of this current study appear to confirm these previous findings.
When using the visual assessment adopted in this paper, there was little difference between CTA and TFL-IOMP. The main differences were identified on a more subjective comparison between the two modalities. Other visual assessment scales were considered, such as the visual analogue scale used by MacDonald et al. (2002) . The study compared a visual analogue scale with a numeric scoring system. It was concluded that whilst both techniques were reproducible and repeatable, the numeric scoring scale possessed a number of inherent deficiencies, which suggested it was not the method of choice for assessing IOMP. The visual analogue scale was considered more accurate when assessing patients with either a very well-developed or very poorly developed portal vasculature, although assessment was less reliable in those patients where the portal vasculature was of intermediate development. For these reasons, use of a visual analogue scale was not considered appropriate in this study.
We conclude that in the majority of EHPSS shunt types, preoperative CTA identified intrahepatic portal arborisation to a similar degree as that shown using TFL-IOMP. Subjectively, however, contrast enhancement and the size of the intrahepatic portal vasculature was considered the best with TFL-IOMP. However, importantly, TFL-IOMP is undertaken at the time of shunt attenuation surgery and provides dynamic results, which are instantaneously available at the time of surgery. Although not specifically investigated in the current study, TFL-IOMP has a number of specific attributes not available in preoperative CTA. These include the potential to measure portal mesenteric venous pressure, the confirmation that the shunting vessel has been correctly identified and ligated at the appropriate site and that only one shunting vessel is present (White et al . 2003 , Lee et al . 2006 , Lipscomb et al . 2009 ). These factors have been shown previously to be important in decision-making and prognosis at the time of shunt attenuation surgery (White et al . 2003 , Lee et al . 2006 , Lipscomb et al . 2009 ). We, therefore, conclude that TFL-IOMP provides additional information to preoperative CTA in the clinical management of patients with EHPSSs.
